(function(){var loadHandler=window['sl_{4D8E5DBA-A9FD-4AA9-B20B-4FE82EEC1058}'];loadHandler&&loadHandler(4, '<div id="spr0_31597b"><div id="spr1_31597b" class="kern slide"><img id="img1_31597b" src="data/img1.png" width="960px" height="720px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_31597b" class="kern slide"><div id="spr3_31597b" style="left:48px;top:9.623px;"><div style="width:0px;"><span id="txt0_31597b" data-width="544.804688" style="left:173.792px;top:-0.918px;">Aim/Research questions</span></div></div><div id="spr4_31597b" style="left:23.578px;top:75.518px;"><div id="spr5_31597b"><img id="img0_31597b" src="data/img7.png" width="619.674" height="518.31" alt=""/></div><div id="spr6_31597b" style="left:-0.003px;top:44.005px;"><div style="width:0px;"><span id="txt1_31597b" data-width="39.156250" style="left:103.236px;top:-15.499px;">Trial</span></div></div><div id="spr7_31597b" style="left:488.753px;top:44.005px;"><div style="width:0px;"><span id="txt2_31597b" data-width="84.304688" style="left:-179.995px;top:-17.436px;">REWIND</span></div></div><div id="spr8_31597b" style="left:914.951px;top:0.805px;"><div style="width:0px;"><span id="txt3_31597b" data-width="150.656250" style="left:-451.662px;top:-3.036px;">UK Prospective</span></div><div style="width:0px;"><span id="txt4_31597b" data-width="150.023438" style="left:-451.355px;top:25.764px;">Diabetes Study</span></div><div style="width:0px;"><span id="txt5_31597b" data-width="75.515625" style="left:-418.336px;top:54.564px;">(UKPDS</span></div><div style="width:0px;"><span id="txt6_31597b" style="left:-342.669px;top:54.564px;">)</span></div></div><div id="spr9_31597b" style="left:-0.003px;top:184.075px;"><div style="width:0px;"><span id="txt7_31597b" data-width="88.916672" style="left:19.122px;top:-90.709px;">Number o</span></div><div style="width:0px;"><span id="txt8_31597b" style="left:108.122px;top:-90.709px;">f</span></div><div style="width:0px;"><span id="txt9_31597b" data-width="105.697922" style="left:119.789px;top:-90.709px;">participants</span></div></div><div id="spr10_31597b" style="left:488.753px;top:184.075px;"><div style="width:0px;"><span id="txt10_31597b" data-width="54.644531" style="left:-165.162px;top:-91.047px;">9,901</span></div></div><div id="spr11_31597b" style="left:914.951px;top:176.827px;"><div style="width:0px;"><span id="txt11_31597b" data-width="54.644531" style="left:-404.085px;top:-91.047px;">5,102</span></div></div><div id="spr12_31597b" style="left:-0.003px;top:273.89px;"><div style="width:0px;"><span id="txt12_31597b" data-width="103.645836" style="left:70.736px;top:-135.617px;">Drug tested</span></div></div><div id="spr13_31597b" style="left:488.753px;top:273.89px;"><div style="width:0px;"><span id="txt13_31597b" data-width="115.078125" style="left:-231.745px;top:-135.954px;">Dulaglutide</span></div><div style="width:0px;"><span id="txt14_31597b" class="relpos" data-width="11.613281" style="left:-117.079px;top:-135.954px;">, </span> <span id="txt15_31597b" class="relpos" style="left:-117.085px;top:-135.954px;">a</span></div><div style="width:0px;"><span id="txt16_31597b" data-width="49.769531" style="left:-93.912px;top:-135.954px;">dded</span></div><div style="width:0px;"><span id="txt17_31597b" data-width="138.820313" style="left:-206.899px;top:-107.154px;">to the existing</span></div><div style="width:0px;"><span id="txt18_31597b" data-width="190.125000" style="left:-232.245px;top:-78.354px;">antihyperglycaemic</span></div><div style="width:0px;"><span id="txt19_31597b" data-width="90.222656" style="left:-182.839px;top:-49.554px;">regimens</span></div></div><div id="spr14_31597b" style="left:914.951px;top:266.641px;"><div style="width:0px;"><span id="txt20_31597b" data-width="108.703125" style="left:-430.739px;top:-135.954px;">Metformin</span></div></div><div id="spr15_31597b" style="left:-0.003px;top:536.504px;"><div style="width:0px;"><span id="txt21_31597b" data-width="77.645836" style="left:83.596px;top:-266.924px;">Regimen</span></div></div><div id="spr16_31597b" style="left:488.753px;top:536.504px;"><div style="width:0px;"><span id="txt22_31597b" data-width="124.335938" style="left:-199.972px;top:-267.261px;">Once weekly</span></div></div><div id="spr17_31597b" style="left:914.951px;top:529.256px;"><div style="width:0px;"><span id="txt23_31597b" data-width="48.140625" style="left:-400.835px;top:-267.261px;">Daily</span></div></div><div id="spr18_31597b" style="left:-0.003px;top:626.319px;"><div style="width:0px;"><span id="txt24_31597b" data-width="153.156250" style="left:45.969px;top:-311.831px;">Mean age (years)</span></div></div><div id="spr19_31597b" style="left:488.753px;top:640.719px;"><div style="width:0px;"><span id="txt25_31597b" data-width="24.328125" style="left:-149.995px;top:-326.569px;">66</span></div></div><div id="spr20_31597b" style="left:914.951px;top:619.071px;"><div style="width:0px;"><span id="txt26_31597b" data-width="24.328125" style="left:-388.919px;top:-312.169px;">53</span></div></div><div id="spr21_31597b" style="left:-0.003px;top:716.133px;"><div style="width:0px;"><span id="txt27_31597b" style="left:69.179px;top:-356.739px;">F</span></div><div style="width:0px;"><span id="txt28_31597b" data-width="96.781250" style="left:78.699px;top:-356.739px;">emales (%)</span></div></div><div id="spr22_31597b" style="left:488.753px;top:730.533px;"><div style="width:0px;"><span id="txt29_31597b" data-width="24.328125" style="left:-149.995px;top:-371.476px;">46</span></div></div><div id="spr23_31597b" style="left:914.951px;top:708.885px;"><div style="width:0px;"><span id="txt30_31597b" data-width="24.328125" style="left:-388.919px;top:-357.076px;">41</span></div></div><div id="spr24_31597b" style="left:-0.003px;top:805.948px;"><div style="width:0px;"><span id="txt31_31597b" data-width="223.947922" style="left:10.619px;top:-401.646px;">Median follow-up (years)</span></div></div><div id="spr25_31597b" style="left:488.753px;top:820.348px;"><div style="width:0px;"><span id="txt32_31597b" data-width="30.386719" style="left:-152.995px;top:-416.383px;">5.4</span></div></div><div id="spr26_31597b" style="left:914.951px;top:798.7px;"><div style="width:0px;"><span id="txt33_31597b" data-width="24.328125" style="left:-388.919px;top:-401.983px;">10</span></div></div><div id="spr27_31597b" style="left:-0.003px;top:895.763px;"><div style="width:0px;"><span id="txt34_31597b" data-width="159.416672" style="left:42.692px;top:-446.553px;">Number of events</span></div></div><div id="spr28_31597b" style="left:488.753px;top:924.563px;"><div style="width:0px;"><span id="txt35_31597b" data-width="48.656250" style="left:-202.079px;top:-475.691px;">1257</span></div><div style="width:0px;"><span id="txt36_31597b" data-width="74.261719" style="left:-147.912px;top:-475.691px;">(12.6%)</span></div><div style="width:0px;"><span id="txt37_31597b" data-width="92.988281" style="left:-184.245px;top:-446.891px;">(MACE-3)</span></div></div><div id="spr29_31597b" style="left:914.951px;top:888.514px;"><div style="width:0px;"><span id="txt38_31597b" data-width="128.273438" style="left:-441.002px;top:-446.891px;">1638 (32,1%)</span></div><div style="width:0px;"><span id="txt39_31597b" data-width="92.988281" style="left:-423.169px;top:-418.091px;">(MACE-3)</span></div></div></div><div id="spr30_31597b" style="left:650.132px;top:75.518px;"><div style="width:0px;"><span id="txt40_31597b" data-width="117.251297" style="left:9.6px;top:59.72px;">PROPOSAL</span></div><div style="width:0px;"><span id="txt41_31597b" class="nokern relpos" dir="auto" style="left:9.6px;top:123.611px;">•</span> <span id="txt42_31597b" class="relpos" data-width="21.127605" style="left:36.731px;top:119.622px;">P </span> <span id="txt43_31597b" class="relpos" data-width="180.537109" style="left:36.724px;top:119.622px;">– UK population</span></div><div style="width:0px;"><span id="txt44_31597b" class="nokern relpos" dir="auto" style="left:9.6px;top:157.051px;">•</span> <span id="txt45_31597b" class="relpos" style="left:36.731px;top:153.062px;">I</span> <span id="txt46_31597b" class="relpos" data-width="93.824875" style="left:36.724px;top:153.062px;"> – GLP-1</span></div><div style="width:0px;"><span id="txt47_31597b" data-width="141.844406" style="left:45.6px;top:180.78px;">(dulaglutide)</span></div><div style="width:0px;"><span id="txt48_31597b" class="nokern relpos" dir="auto" style="left:9.6px;top:217.851px;">•</span> <span id="txt49_31597b" class="relpos" style="left:36.731px;top:213.862px;">C</span> <span id="txt50_31597b" class="relpos" data-width="173.894531" style="left:36.724px;top:213.862px;"> – vs metformin</span></div><div style="width:0px;"><span id="txt51_31597b" class="nokern relpos" dir="auto" style="left:9.6px;top:251.291px;">•</span> <span id="txt52_31597b" class="relpos" style="left:36.731px;top:247.302px;">O</span> <span id="txt53_31597b" class="relpos" data-width="117.921227" style="left:36.724px;top:247.302px;"> – MACE-3</span></div><div style="width:0px;"><span id="txt54_31597b" class="nokern relpos" dir="auto" style="left:9.6px;top:284.731px;">•</span> <span id="txt55_31597b" class="relpos" style="left:36.731px;top:280.742px;">T</span> <span id="txt56_31597b" class="relpos" data-width="112.033203" style="left:36.724px;top:280.742px;"> –  5 years</span></div><div style="width:0px;"><span id="txt57_31597b" class="nokern relpos" dir="auto" style="left:9.6px;top:351.611px;">•</span> <span id="txt58_31597b" class="relpos" data-width="148.499359" style="left:36.731px;top:347.622px;">HYPOTHESIS:</span></div><div style="width:0px;"><span id="txt59_31597b" data-width="200.353516" style="left:45.6px;top:375.34px;">reduce number of</span></div><div style="width:0px;"><span id="txt60_31597b" data-width="185.905609" style="left:45.6px;top:402.7px;">events (MACE-3)</span></div></div><div id="spr31_31597b" style="left:9.538px;top:638.587px;"><div style="width:0px;"><span id="txt61_31597b" class="nokern" data-width="918.339844" style="left:9.6px;top:3.393px;">Gerstein HC, Colhoun HM, Dagenais GR, et al.; REWIND Investigators. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind,</span></div><div style="width:0px;"><span id="txt62_31597b" class="nokern" data-width="451.236969" style="left:9.6px;top:19.393px;">randomised placebo-controlled trial. Lancet. 2019 Jul 13;394(10193):121-130.</span></div><div style="width:0px;"><span id="txt63_31597b" class="nokern" data-width="845.683594" style="left:9.6px;top:35.113px;">King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999</span></div><div style="width:0px;"><span id="txt64_31597b" class="nokern" data-width="91.634109" style="left:9.6px;top:51.113px;">Nov;48(5):643-8.</span></div></div><div id="spr32_31597b" style="left:9.538px;top:612.169px;"><div style="width:0px;"><span id="txt65_31597b" data-width="72.056976" style="left:9.6px;top:2.83px;">MACE-3</span></div><div style="width:0px;"><span id="txt66_31597b" data-width="606.572571" style="left:80.1px;top:2.83px;">: nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death.</span></div></div></div></div>', '{"s":[]}');})();